Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Tuberculosis Diagnostics Market 2023 – By Test Type (Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types), By Disease Stage (Latent Tuberculosis, Active Tuberculosis), By End-User (Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities), And By Region, Opportunities And Strategies – Global Forecast To 2032

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Starting Price : $5000.00 | Pages : 352 | Published : May 2023 | | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Tuberculosis Diagnostics Market Definition

Tuberculosis (TB) is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

The tuberculosis diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of tuberculosis diagnostics that are used for diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testing.

Tuberculosis Diagnostics Market Size

The global tuberculosis diagnostics market reached a value of nearly $1,989.7 million in 2022, having increased at a compound annual growth rate (CAGR) of 3.6% since 2017. The market is expected to grow from $1,989.7 million in 2022 to $2,760.6 million in 2027 at a rate of 6.8%. The market is then expected to grow at a CAGR of 7.6% from 2027 and reach $3,976.4 million in 2032.  

Growth in the historic period resulted from the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities and the rise in the adoption of nucleic acid testing. Factors that negatively affected growth in the historic period were COVID-19 impact, the low healthcare access in developing countries and the lack of skilled medical professionals.

Going forward, strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities and the emergence of drug-resistant TB will drive the market. Factors that could hinder the growth of the tuberculosis diagnostics market in the future include the Russia-Ukraine war impact and the stigma and discrimination associated with tuberculosis.

Tuberculosis Diagnostics Market Drivers

The key drivers of the tuberculosis diagnostics market include:

Increasing FDA Approvals For Tuberculosis Diagnostics

During the forecast period, the increasing US Food and Drug Administration (FDA) approvals for tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market. For example, in March 2023, PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, announced that the US FDA has approved the use of two additional cell isolation instruments Auto-Pure 24 and Auto-Pure 20B platforms manufactured by Allsheng Instruments. Further, in October 2022, PerkinElmer Oxford Immunotec announced that the FDA has approved the use of the T-Cell Select reagent kit for the automation of its T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select is a peripheral blood mononuclear cell (PBMC) isolation reagent that uses positive selection of PBMCs with magnetic bead-based cell separation to automate and simplify the preparation of cells for the T-SPOT.TB test, a globally regulated ELISPOT IGRA for detecting latent TB infection. Therefore, the increasing approvals for new tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market.

Tuberculosis Diagnostics Market Restraints

The key restraints on the tuberculosis diagnostics market include:

Stigma And Discrimination

The stigma associated with tuberculosis is a significant challenge all over the world, leading to increased infections, delayed treatment and even potentially fatal consequences. Poverty promotes TB spread due to crowded living circumstances, a lack of healthcare and poor sanitation. TB stigma exists in the majority, if not all, poorer/developing countries. For example, much of the TB stigma identified in Uganda, was also found in China, Indonesia, the Philippines, Zambia, Sudan, Ethiopia, and other developing parts of the world. A significant portion of the stigma associated with tuberculosis stems from its association with HIV and AIDS. In many parts of the world, the symptoms of the two are frequently confused. The stigma associated with tuberculosis might lead to persons postponing treatment in order to avoid the social implications of being recognized as having TB. Even when people want to seek treatment, they are frequently ignored. Therefore, the stigma associated with tuberculosis may negatively affect the growth of the tuberculosis diagnostics market.

Tuberculosis Diagnostics Market Trends

Major trends influencing the tuberculosis diagnostics market include:

Next Generation Sequencing (NGS) Platform For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. With identifying possible new therapeutic targets, NGS-based TB diagnostics have the capacity provide valuable insights on TB transmission and epidemiology of the disease. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species. Also, in July 2021, Metropolis Healthcare, an India-based chain of diagnostics, launched NEXTGEN TB whole genome sequencing of tuberculosis utilizing the Next Generation Sequencing (NGS) platform for rapid identification of drug resistance in TB patients and providing genotypic level information on drug-resistant genes for up to 18 TB antibiotics. Partnering with HaystackAnalytics (a start-up incubated at SINE, IIT Bombay), Metropolis Healthcare has become the first diagnostic service provider in India to launch NGS as a routine diagnostic test, and plans to provide this test in Sri Lanka, Mauritius, the UAE, Kenya, Zambia, Ghana, Tanzania and three other African countries to help their fight against tuberculosis.

Product Innovations

Product innovations are a key trend in the tuberculosis diagnostics market, as companies look to stay competitive and meet the evolving needs and preferences of consumers. The innovation in a product can generate buzz and excitement, which can drive sales and increase brand awareness. Companies in the tuberculosis diagnostics market are focusing on product innovations and developing new product solutions to strengthen their position in the market. For example, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, launched the BD MAX MDR TB (Tuberculosis) test, a diagnostic test to enable clinicians to rapidly test for tuberculosis and multidrug resistance as a first- line test, which is performed on BD MAX molecular diagnostic system. Clinicians use the test to simultaneously detect bacteria that cause TB and determine if the bacteria contain mutations associated with resistance to two important first-line drugs, Isoniazid (INH) and Rifampicin (RIF).  Further, in July 2020, the Foundation for Innovative New Diagnostics (FIND), a Switzerland-based health non-profit and Cepheid Inc, a US-based molecular diagnostics company, launched the Xpert® MTB/XDR* test, a new drug-resistant tuberculosis profiling test that gives result in 90 minutes. This test is used to empower clinicians to quickly prescribe treatment regimens for extensively drug-resistant TB (XDR-TB).

Opportunities And Recommendations In The Tuberculosis Diagnostics Market

Opportunities –The top opportunities in the tuberculosis diagnostics market by test types will arise in the smear microscopy market, which will gain $193.3 million of global annual sales by 2027. The top opportunities in the tuberculosis diagnostics market by disease stage will arise in the active tuberculosis market, which will gain $533.2 million of global annual sales by 2027. The top opportunities in the tuberculosis diagnostics market by end user will arise in the hospitals and diagnostic laboratories market, which will gain $325.4 million of global annual sales by 2027. The tuberculosis diagnostics market size will gain the most in the USA at $227.5 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the tuberculosis diagnostics companies to increase focus on next generation sequencing (NGS) platform for TB diagnostics, focus on product innovations, focus on artificial intelligence (AI)-based tuberculosis diagnostics, focus on use of portable devices, focus on fast-growing test types, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to focus on fast-growing end-users and target the elderly population.

Tuberculosis Diagnostics Market Segmentation

The tuberculosis diagnostics market is segmented by test type, by disease stage and by end-user.
By Test Type -
The tuberculosis diagnostics market is segmented by test type into
    • a) Radiographic Tests
    • b) Nucleic Acid Testing
    • c) Cytokine Detection Tests
    • d) Drug Resistance Tests
    • e) Skin Test / Mantoux Test (TST)
    • f) Blood/Serology Test
    • g) Smear Microscopy Tests
    • h) Cell Culture-Based Tests
    • i) Other Test Types
The smear microscopy tests market was the largest segment of the tuberculosis diagnostics market by test types, accounting for $496.9 million or 25.0% of the total market in 2022. The nucleic acid testing market is expected to be the fastest-growing segment going forward at a CAGR of 7.1%.
By Disease Stage-
The tuberculosis diagnostics market is segmented by disease stage into
    • a) Latent Tuberculosis
    • b) Active Tuberculosis
The active tuberculosis market was the largest segment of the tuberculosis diagnostics market by disease stage, accounting for $1,415.5 million or 71.1% of the total market in 2022. The latent tuberculosis market is expected to be the fastest-growing segment going forward at a CAGR of 7.2%.
By End-User-
The tuberculosis diagnostics market is segmented by end-user into
    • a) Hospitals And Diagnostic Laboratories
    • b) Physician’s Office Laboratories
    • c) Reference Laboratories
    • d) Academics And Research Facilities
The hospitals and diagnostic laboratories market was the largest segment of the tuberculosis diagnostics market by end users, accounting for $832.6 million or 41.8% of the total market in 2022. The physician’s office laboratories market is expected to be the fastest-growing segment going forward at a CAGR of 6.9%.
By Geography - The tuberculosis diagnostics market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
Asia Pacific was the largest region in the tuberculosis diagnostics market, accounting for 39.8% of the global market in 2022. It was followed by North America, Western Europe and the other regions. Going forward, the fastest growing regions in the tuberculosis diagnostics market will be Asia Pacific and North America, where growth will be at CAGRs of 8.1% and 6.7% respectively from 2022-2027.

Tuberculosis Diagnostics Market Competitive Landscape

Major Competitors are:

  • Beckton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Qiagen N.V.
  • BioMerieux SA
  • Danaher Corporation (Cepheid Inc.)

    • Other Competitors Include:

  • PerkinElmer
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Roche Diagnostics India Pvt Ltd
  • Abbott India Limited
  • Qiagen India Pvt Ltd
  • BioMérieux India
  • Becton Dickinson Private Limited
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • OriGene Technologies
  • Siemens AG
  • Fresenius
  • Koninklijke Philips
  • Novartis
  • LumiraDx Limited
  • Siemens Healthineers Ukraine,
  • TestLine Clinical Diagnostics s.r.o.
  • Cepheid
  • Hologic
  • Bayer AG
  • Cantel Medical Corporation
  • Meridian Bioscience
  • Johnson & Johnson
  • Abbott laboratories Immunodiagnostic Systems Holdings PLC
  • Mesa Biotech Inc
  • Pfizer
  • Agilent technologies Inc
  • AutoGenomics
  • AdvaCare Pharma
  • Akonni Biosystems Inc
  • Par Pharmaceutical
  • Epistem Limited
  • Gen-Probe
  • QIAGEN SA (Pty) Ltd
  • Abbott Laboratories (South Africa)
  • Sysmex South Africa (Pty) Ltd.
  • Grifols S.A.
  • Siemens Healthineers AG
  • Bio Certica
  • Biovac
  • BixBio

      • Table Of Contents

      1. Executive Summary

      2. Table Of Contents

      3. List Of Figures

      4. List Of Tables

      5. Report Structure

      6. Introduction And Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Tuberculosis Diagnostics Market Definition And Segmentations

      6.4. Market Segmentation By Test Type

      6.4.1. Radiographic Test

      6.4.2. Nucleic Acid Testing

      6.4.3. Cytokine Detection Test

      6.4.4. Drug Resistance Test

      6.4.5. Skin Test/Mantoux Test (TST)

      6.4.6. Blood Test/Serology Test

      6.4.7. Smear Microscopy

      6.4.8. Cultured-Based Tests

      6.4.9. Other Test Types

      6.5. Market Segmentation By Disease Stage

      6.5.1. Latent Tuberculosis

      6.5.2. Active Tuberculosis

      6.6. Market Segmentation By End User

      6.6.1. Hospitals And Diagnostic Laboratories

      6.6.2. Physician’s Office Laboratories

      6.6.3. Reference Laboratories

      6.6.4. Academics And Research Facilities

      7. Major Market Trends

      7.1. Next Generation Sequencing (NGS) Platform For TB Diagnostics

      7.2. Product Innovations

      7.3. T Cell Tests For TB Infection

      7.4. Artificial Intelligence (AI)-Based Tuberculosis Diagnostics

      7.5. Use Of Portable Devices

      7.6. Collaborations Between Governments And Manufacturers

      8. Global Market Size and Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

      8.2.1. Market Drivers 2017 – 2021

      8.2.2. Market Restraints 2017 – 2022

      8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      8.3.1. Market Drivers 2022 – 2027

      8.3.2. Market Restraints 2022 – 2027

      9. Global Tuberculosis Diagnostics Market Segmentation

      9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.3. Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10. Tuberculosis Diagnostics Market, Regional and Country Analysis

      10.1. Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.2. Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Taxes levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.4. Asia-Pacific Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.5. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.6. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.7. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.8. Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis

      11.9. China Market

      11.10. Summary

      11.11. Market Overview

      11.11.1. Country Information

      11.11.2. Market Information

      11.11.3. Background Information

      11.11.4. Government Initiatives

      11.11.5. Regulations

      11.11.6. Regulatory Bodies

      11.11.7. Major Associations

      11.11.8. Taxes levied

      11.11.9. Corporate tax structure

      11.11.10. Investments

      11.11.11. Major Companies

      11.12. China Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.13. China Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.14. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.15. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.16. China Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.17. India Market

      11.18. India Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.19. India Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.20. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.21. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.22. India Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.23. Japan Market

      11.24. Japan Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.25. Japan Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.26. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.27. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.28. Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.29. Australia Market

      11.30. Australia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.31. Australia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.32. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.33. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.34. Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.35. Indonesia Market

      11.36. Indonesia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.37. Indonesia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.38. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.39. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.40. Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.41. South Korea Market

      11.42. South Korea Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.43. South Korea Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.44. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.45. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.46. South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes levied

      12.2.9. Corporate tax structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.4. Western Europe Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.5. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.6. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.7. Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.8. Western Europe Tuberculosis Diagnostics Market: Country Analysis

      12.9. UK Market

      12.10. UK Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.11. UK Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.12. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.13. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.14. UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.15. Germany Market

      12.16. Germany Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.17. Germany Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.18. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.19. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.20. Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.21. France Market

      12.22. France Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.23. France Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.24. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.25. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.26. France Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulation

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.4. Eastern Europe Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.5. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.6. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.7. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.8. Eastern Europe Tuberculosis Diagnostics Market: Country Analysis

      13.9. Russia Market

      13.10. Russia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.11. Russia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.12. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.13. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.14. Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.4. North America Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.5. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.6. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.7. North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.8. North America Tuberculosis Diagnostics Market: Country Analysis

      14.9. USA Market

      14.10. Summary

      14.11. Market Overview

      14.11.1. Country Information

      14.11.2. Market Information

      14.11.3. Background Information

      14.11.4. Government Initiatives

      14.11.5. Regulations

      14.11.6. Regulatory Bodies

      14.11.7. Major Associations

      14.11.8. Taxes levied

      14.11.9. Corporate Tax Structure

      14.11.10. Investments

      14.11.11. Major Companies

      14.12. USA Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.13. USA Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.14. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.15. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.16. USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.4. South America Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.5. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.6. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.7. South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.8. South America Tuberculosis Diagnostics Market: Country Analysis

      15.9. Brazil Market

      15.10. Brazil Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.11. Brazil Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.12. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.13. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.14. Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.4. Middle East Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.5. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.6. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.7. Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      17.4. Africa Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      17.5. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.6. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.7. Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18. Competitive Landscape and Company Profiles

      18.1. Company Profiles

      18.2. Becton Dickinson and Company (BD)

      18.2.1. Company Overview

      18.2.2. Products And Services

      18.2.3. Business Strategy

      18.2.4. Financial Overview

      18.3. F. Hoffmann-La Roche Ltd

      18.3.1. Company Overview

      18.3.2. Products And Services

      18.3.3. Business Strategy

      18.3.4. Financial Overview

      18.4. Qiagen N.V.

      18.4.1. Company Overview

      18.4.2. Products And Services

      18.4.3. Business Strategy

      18.4.4. Financial Overview

      18.5. BioMerieux SA

      18.5.1. Company Overview

      18.5.2. Products And Services

      18.5.3. Business Strategy

      18.5.4. Financial Overview

      18.6. Danaher Corporation

      18.6.1. Company Overview

      18.6.2. Products And Services

      18.6.3. Business Strategy

      18.6.4. Financial Overview

      19. Key Mergers And Acquisitions

      19.1. Molbio Diagnostics Pvt. Ltd. Acquired Prognosys Medical Systems

      19.2. Fujifilm Collaborated with Qure.ai

      19.3. SD Biosensor Inc. Acquired Relab Srl

      19.4. Roche Acquired GenMark Diagnostics

      19.5. PerkinElmer Acquired Oxford Immunotec

      20. Opportunities And Strategies

      20.1. Global Tuberculosis Diagnostics Market In 2027 – Countries Offering Most New Opportunities

      20.2. Global Tuberculosis Diagnostics Market In 2027 – Segments Offering Most New Opportunities

      20.3. Global Tuberculosis Diagnostics Market In 2027 – Growth Strategies

      20.3.1. Market Trend Based Strategies

      20.3.2. Competitor Strategies

      21. Tuberculosis Diagnostics Market, Conclusions And Recommendations

      21.1. Conclusions

      21.2. Recommendations

      21.2.1. Product

      21.2.2. Place

      21.2.3. Price

      21.2.4. Promotion

      21.2.5. People

      22. Appendix

      22.1. Market Data Sources

      22.2. Research Methodology

      22.3. Currencies

      22.4. The Business Research Company

      22.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 4: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 5: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 6: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 7: Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 8: Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 9: Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 10: Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 11: Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 12: Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 13: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
    • Table 14:  Asia-Pacific Population, By Country, 2017-2027, Millions
    • Table 15: Asia-Pacific, TB Incidence, By Country, 2021
    • Table 16: Asia-Pacific, Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 17: Asia-Pacific Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 18: Asia-Pacific Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 19: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 20: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 21: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 22: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 23: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 24: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 25: China GDP Per Capita, 2017-2022, $
    • Table 26:  China Population, 2017-2027, Millions
    • Table 27: China, TB Incidence, 2021
    • Table 28: China Medical Equipment Market Size, 2017-2027, $ Billion
    • Table 29: China Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 30: China Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 31: China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 32: China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 33: China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 34: China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 35: China Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 36: China Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 37: India Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 38: India Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 39: India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 40: India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 41: India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 42: India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 43: India Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 44: India Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 45: Japan Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 46: Japan Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 47: Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 48: Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 49: Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 50: Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 51: Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 52: Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 53: Australia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 54: Australia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 55: Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 56: Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 57: Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 58: Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 59: Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 60: Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 61: Indonesia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 62: Indonesia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 63: Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 64: Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 65: Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 66: Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 67: Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 68: Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 69: South Korea Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 70: South Korea Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 71: South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 72: South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 73: South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 74: South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 75: South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 76: South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 77: Western Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 78:  Western Europe Population, By Country, 2017-2027, Millions
    • Table 79: Western Europe, TB Incidence, By Country, 2021
    • Table 80: Western Europe Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 81: Western Europe Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 82: Western Europe Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 83: Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 84: Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 85: Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 86: Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 87: Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 88: Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 89: UK Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 90: UK Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 91: UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 92: UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 93: UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 94: UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 95: UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 96: UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 97: Germany Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 98: Germany Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 99: Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 100: Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 101: Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 102: Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 103: Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 104: Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 105: France Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 106: France Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 107: France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 108: France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 109: France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 110: France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 111: France Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 112: France Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 113: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 114:  Eastern Europe Population, By Country, 2017-2027, Millions
    • Table 115: Eastern Europe, TB Incidence, By Country, 2021
    • Table 116: Eastern Europe Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 117: Eastern Europe Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 118: Eastern Europe Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 119: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 120: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 121: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 122: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 123: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 124: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 125: Russia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 126: Russia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 127: Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 128: Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 129: Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 130: Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 131: Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 132: Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 133: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 134:  North America Population, By Country, 2017-2027, Millions
    • Table 135: North America, TB Incidence, By Country, 2021
    • Table 136: North America Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 137: North America Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 138: North America Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 139: North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 140: North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 141: North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 142: North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 143: North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 144: North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 145: USA GDP Per Capita, 2017-2022, $
    • Table 146:  USA Population, 2017-2027, Millions
    • Table 147: USA, TB Incidence, 2021
    • Table 148: USA Medical Equipment Market Size, 2017-2027, $ Billion
    • Table 149: USA Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 150: USA Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 151: USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 152: USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 153: USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 154: USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 155: USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 156: USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 157: South America GDP Per Capita, By Country, 2017-2022, $
    • Table 158:  South America Population, By Country, 2017-2027, Millions
    • Table 159: South America, TB Incidence, By Country, 2021
    • Table 160: South America Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 161: South America Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 162: South America Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 163: South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 164: South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 165: South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 166: South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 167: South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 168: South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 169: Brazil Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 170: Brazil Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 171: Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 172: Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 173: Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 174: Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 175: Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 176: Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 177: Middle East GDP Per Capita, By Country, 2017-2022, $
    • Table 178:  Middle East Population, By Country, 2017-2027, Millions
    • Table 179: Middle East, TB Incidence, By Country, 2021
    • Table 180: Middle East Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 181: Middle East Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 182: Middle East Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 183: Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 184: Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 185: Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 186: Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 187: Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 188: Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 189: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 190:  Africa Population, By Country, 2017-2027, Millions
    • Table 191: Africa, TB Incidence, By Country, 2021
    • Table 192: Africa Medical Equipment Market Size, By Country, 2017-2027, $ Billion
    • Table 193: Africa Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Table 194: Africa Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 195: Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 196: Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 197: Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 198: Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 199: Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 200: Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 201: Global Tuberculosis Diagnostics Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 202: BD – Financial Performance, 2017– 2021, $ Billion
    • Table 203: Roche – Financial Performance, 2017– 2021, $ Billion
    • Table 204: QIAGEN – Financial Performance, 2017– 2021, $ Billion
    • Table 205: BioMérieux – Financial Performance, 2017 – 2021, $ Billion
    • Table 206: Danaher – Financial Performance, 2017– 2021, $ Billion
    • Table 207: Global Tuberculosis Diagnostics Market Size Gain ($ Million), 2022 – 2027, By Country
    • Table 208: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By Test Type, 2022 – 2027
    • Table 209: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By Disease Stage, 2022 – 2027
    • Table 210: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By End User, 2022 – 2027
    • Table 211: Tuberculosis Diagnostics - Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Tuberculosis Diagnostics Market Segmentation By Test Type
    • Figure 3: Global Tuberculosis Diagnostics Market Segmentation By Disease Stage
    • Figure 4: Global Tuberculosis Diagnostics Market Segmentation By End User
    • Figure 5: Global Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 6: Global Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 7: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 8: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 9: Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 10: Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 11: Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 12: Asia-Pacific Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 13: Asia-Pacific Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 14: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 15: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 16: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 17: China Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 18: China Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 19: China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 20: China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 21: China Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 22: India Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 23: India Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 24: India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 25: India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 26: India Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 27: Japan Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 28: Japan Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 29: Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 30: Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 31: Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 32: Australia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 33: Australia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 34: Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 35: Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 36: Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 37: Indonesia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 38: Indonesia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 39: Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 40: Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 41: Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 42: South Korea Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 43: South Korea Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 44: South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 45: South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 46: South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 47: Western Europe Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 48: Western Europe Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 49: Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 50: Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 51: Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 52: UK Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 53: UK Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 54: UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 55: UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 56: UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 57: Germany Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 58: Germany Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 59: Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 60: Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 61: Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 62: France Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 63: France Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 64: France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 65: France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 66: France Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 67: Eastern Europe Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 68: Eastern Europe Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 69: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 70: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 71: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 72: Russia Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 73: Russia Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 74: Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 75: Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 76: Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 77: North America Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 78: North America Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 79: North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 80: North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 81: North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 82: USA Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 83: USA Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 84: USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 85: USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 86: USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 87: South America Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 88: South America Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 89: South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 90: South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 91: South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 92: Brazil Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 93: Brazil Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 94: Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 95: Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 96: Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 97: Middle East Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 98: Middle East Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 99: Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 100: Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 101: Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 102: Africa Tuberculosis Diagnostics Market, Historic, 2017 – 2022, $ Million
    • Figure 103: Africa Tuberculosis Diagnostics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 104: Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 105: Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 106: Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 107: Global Tuberculosis Diagnostics Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 108: BD – Financial Performance, 2017– 2021, $ Billion
    • Figure 109: Roche – Financial Performance, 2017– 2021, $ Billion
    • Figure 110: QIAGEN – Financial Performance, 2017– 2021, $ Billion
    • Figure 111: BioMérieux – Financial Performance, 2017 – 2021, $ Billion
    • Figure 112: Danaher – Financial Performance, 2017– 2021, $ Billion
    Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
    Read More
    Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
    Read More
    What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
    Read More
    How Will The Laryngoscope Market Grow In 2022?
    Read More
    The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
    Read More
    Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare Settings), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, Others), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Others), And By Region, Opportunities And Strategies – Global Forecast To 2031
    View Report
    Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD), By End-Use (Hospitals, Clinical Laboratories, Home Care), Opportunities And Strategies - Global Forecast To 2030
    View Report
    Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report
    Sterilization Equipment And Disinfectants Market 2023 – By Product Type (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End Use (Hospitals And Clinics, Clinical Laboratories, Pharmaceutical Companies, Other Industries, Non-Industrial Use), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes), By Type Of Product( Plastics & Polymers, Chlor-Alkali And Inorganics, Olefins, Aromatics, Olefin Derivatives, Syngas Chemicals), Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2022
    View Report
    Masks (N95 Respirators And Other Surgical Masks) Market 2022 – By Type (N95 Respirator, Common Grade Surgical Masks, Others (Comfort Masks/Dust Masks)), By End User (Hospitals and Clinics, Individual, Other End Users), By Nature (Reusable, Disposable), And By Region, Opportunities And Strategies – Global Forecast To 2031 
    View Report